Colchicine may reduce myocardial damage after non-bypass heart surgery.

Published Date: 17 Feb 2023

China: Low-dose colchicine helps protect myocardium in surgery patients without CABG (coronary artery bypass graft).

Read Full News

Latest News

Does Vitiligo Raise Risk for Mental Health Disorders?

A retrospective study shows that patients with vitiligo face a high burden of mental health disorders, with the morbidity profile matching that of atopic dermatitis but not psoriasis.

Obinutuzumab Lowers Lupus Disease Activity in Phase 3 Trial

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

SLIT Appears Safe and Effective for Dust Mite Allergy

House dust mite sublingual immunotherapy reduces symptoms, decreases medication use, and shows a favorable safety profile in adults and adolescents with allergic rhinoconjunctivitis.

Measles Cases in South Carolina Rise by 2 to 993, State Health Department Says

Measles cases in South Carolina rose to 993 on Tuesday, state health ⁠data showed, including two cases since the last update on Friday.

Shingles Vaccine Safe in Patients With Rheumatic Diseases

A herpes zoster vaccine is safe in adults with autoimmune rheumatic disease and elicits a strong immune response, but responses are weaker in those on rituximab or mycophenolate, per a phase 4 study.

Skin Inflammation Therapies Might Target Depression

Anti-inflammatory therapies that are highly effective for inflammatory skin diseases might also be relevant to depression because of shared inflammatory pathways.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Todays Updates

Chemoimmunotherapy Boosts Head and Neck Cancer Response

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

Latest News

A retrospective study shows that patients with vitiligo face a high burden of mental health disorders, with the morbidity profile matching that of atopic dermatitis but not psoriasis.

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

House dust mite sublingual immunotherapy reduces symptoms, decreases medication use, and shows a favorable safety profile in adults and adolescents with allergic rhinoconjunctivitis.

Measles cases in South Carolina rose to 993 on Tuesday, state health ⁠data showed, including two cases since the last update on Friday.

A herpes zoster vaccine is safe in adults with autoimmune rheumatic disease and elicits a strong immune response, but responses are weaker in those on rituximab or mycophenolate, per a phase 4 study.

Anti-inflammatory therapies that are highly effective for inflammatory skin diseases might also be relevant to depression because of shared inflammatory pathways.

News All Time

Adrenocortical Carcinoma: Incidence and Survival Over Time

The incidence of adrenocortical carcinoma is stable over time, but the survival for stage IV disease has improved, with the centralisation of care being associated with better survival.

Doctors Raise Their Voices Against AMR

Healthcare professionals are stepping into the spotlight in Lifeline, a musical that blends medicine, music, and a warning about antimicrobial resistance.

Extended Dupilumab Dosing Maintains Efficacy in Nasal Polyps

Dupilumab yields rapid reductions in nasal polyp burden and improvements in smell function; these benefits persist with extended dosing intervals.

Immunoglobulin A Nephropathy: 5 Treatment Approaches to Know

The treatment landscape for IgA nephropathy is rapidly evolving, with therapies focused on mitigating the effects of nephron loss now being combined with immunomodulatory treatments.

Tolvaptan vs Fluid Limits: Do Costs Outweigh pNa Gains?

Although tolvaptan bests fluid restriction at raising plasma sodium concentration, 19% of patients experience overcorrection of sodium increases.

Outpatient RSV in Kids Younger Than 2 Has Distinct Features

In outpatient care, RSV infections in children younger than 2 years present with distinct clinical features and greater illness burden than infections caused by other respiratory viruses.

Pfizer's Eczema Drug Meets Main Goal in Mid-stage Trial, Plans Late-stage Study

U.S. drugmaker Pfizer said on Monday its experimental drug for a ⁠chronic skin disease met the main goal in a mid-stage study.

Gene Therapy Injections for Knee OA: Where Are We At?

Developers of gene therapies to treat knee osteoarthritis are taking the familiar intra-articular route to deliver proteins and molecules directly to the site of the disease.

Women at Higher Risk for Chronic Cough With Age

Experts report that a chronic cough lasting at least 8 weeks disproportionately affects women, with prevalence increasing with age.

FDA Approves Deucravacitinib as First TYK2 Inhibitor for PsA

In clinical trials, more than half of all patients treated with deucravacitinib achieved at least 20% improvement in American College of Rheumatology response criteria.

Risk Factors for Childbirth-Related PTSS Vary in Parents

Prenatal, childbirth-related, and postpartum risk factors drive childbirth-related posttraumatic stress symptoms, with subjective perception and infant health emerging as key predictors.

Fasting-Mimicking Diet Shows Benefit in Crohn’s Disease

Nearly 70% of patients with mild-to-moderate Crohn’s disease following a 5-day-per-month fasting-mimicking diet achieve a clinical response in a controlled trial.

Pediatric Rheumatologist Explains Updated ACR JIA Guidelines

The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS.

Two Drugs Similarly Maintain EGPA Vasculitis Remission

‘There was no signal in favor of rituximab [vs azathioprine] even in patients at high risk for vasculitis relapse,’ said Xavier Puéchal, MD, PhD.

Multiple Vaccines Not Linked to Higher Risk for Reactions

The researchers tested simultaneous administration of routinely recommended vaccines against up to eight pathogens.

Exhaled Compounds May Identify Allergic Rhinitis

Volatile organic compounds in exhaled breath may help distinguish patients with allergic rhinitis from patients with nonallergic rhinitis.

Recommended News For You

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

Scientists discover the 'roadmap' that aggressive cancer uses to spread

ALK Inhibitor Shows Promise in Rare, Progressive Tumor Types

Zebrafish models offer fast, effective guidance for personalized therapies for kids with high-risk cancer

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

Study looks into cancer-related harmful communication.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

Recommended Articles For You

Unleashing the Power of AI: A Systematic Review of Predictive Biomarker Discovery in Immuno-Oncology 

Understanding Colon Cancer: Symptoms, Causes, and Treatment Options  

Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI 

Cancer Vaccines In India: The Latest Hope In The Fight Against Disease 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.

2.

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

3.

Prostate cancer early detection system eliminates need for biopsy.

4.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

5.

These Athletes Weren't Doping. Their Genes Made It Look Like They Did.

1.

Unlocking the Potential of Leukemia Treatment: A New Hope for Patients

2.

What You Need to Know about Hairy Cell Leukemia: A Comprehensive Guide 

3.

Exploring the Use of Bevacizumab in Treating Different Types of Cancers 

4.

Oncolytic Viruses in Breast Cancer: Unlocking Synergy with Novel Combination Therapies

5.

The latest Hematocrit: An Overview of Red Blood Cell Health 

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials

2.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

3.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

5.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot